WHO ICTRP trial
Effectiveness of adding nitazoxanide to the standard triple therapy in the…
PACTR202112686695509 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202112686695509 |
|---|---|
| Public title | Effectiveness of adding nitazoxanide to the standard triple therapy in the eradication of Helicobacter pylori infection |
| Scientific title | Effectiveness of adding nitazoxanide to the standard triple therapy in the eradication of Helicobacter pylori infection |
| Primary sponsor | No |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-4 |
| Countries | Egypt |
| Conditions | Digestive System;Digestive System |
| Interventions | amoxicillin based standard triple therapy;Metronidazole based standard triple therapy;Nitazoxanide based triple therapy;Standard triple therapy plus nitazoxanide |
| Registration date | Nov 13, 2021 |
| Target size | 210 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: